Novo Nordisk A/S
NVONYSEHealthcare● Active
$42.96
$-0.79(-1.81%)
Market Cap$190.9B
P/E Ratio—
52W High$81.44
52W Low$35.12
Novo Nordisk A/S (NVO) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NVO · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $309.06B | $290.40B | $232.26B | $176.95B | $140.80B |
| Cost of Revenue | $58.79B | $44.52B | $35.77B | $28.45B | $23.66B |
| Gross Profit | $250.28B | $245.88B | $196.50B | $148.51B | $117.14B |
| Gross Margin %(computed) | 80.98% | 84.67% | 84.60% | 83.92% | 83.20% |
| Operating Expenses | |||||
| R&D Expenses | $52.04B | $48.06B | $32.44B | $24.05B | $17.77B |
| G&A Expenses | $5.97B | $5.28B | $4.86B | $4.47B | $4.05B |
| Total Operating Expenses | $122.62B | $117.54B | $93.92B | $73.70B | $58.50B |
| Operating Income | $127.66B | $128.34B | $102.57B | $74.81B | $58.64B |
| Operating Margin %(computed) | 41.30% | 44.19% | 44.16% | 42.28% | 41.65% |
| Interest Income | $1.27B | $1.84B | $1.07B | $0.24B | $0.23B |
| Interest Expense | $4.21B | $1.64B | $0.54B | $0.38B | $0.29B |
| Income Before Tax | $130.54B | $127.19B | $104.67B | $69.06B | $59.08B |
| Income Tax Expense | $28.11B | $26.20B | $20.99B | $13.54B | $11.32B |
| Net Income | $102.43B | $100.99B | $83.68B | $55.52B | $47.76B |
| Net Margin %(computed) | 33.14% | 34.78% | 36.03% | 31.38% | 33.92% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $23.06 | $22.67 | $18.67 | $12.26 | $10.40 |
| Wtd Avg Shares | 4.45B | 4.45B | 4.48B | 4.53B | 4.59B |
| EBITDA | $156.73B | $147.94B | $114.63B | $76.80B | $65.39B |
| EBITDA Margin %(computed) | 50.71% | 50.94% | 49.35% | 43.40% | 46.44% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · DKK · B
Explore more Novo Nordisk A/S data
About Novo Nordisk A/S (NVO) Income Statement
Novo Nordisk A/S (NVO) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, NVO reported revenue of $309.06B, gross profit of $250.28B (gross margin 80.98%), and net income of $102.43B — a net profit margin of 33.14%.
Frequently asked questions
NVO · 4 questionsNovo Nordisk A/S (NVO) reported revenue of $309.06B for 2025, up 6.4% year-over-year.
NVO revenueNVO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08